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Chapter I 
Introduction 
1 
Most of the energy required for eukaryotic organisms is obtained from the process 
of electron transport coupled to ATP synthesis, known as oxidative phosphorylation. 
Oxidative phosphorylation takes place in the inner mitochondrial membrane and is 
carried out by five protein complexes, four of which form the mitochondrial electron 
transport chain: NADH-ubiquinone reductase (NQR, complex I), succinate-ubiquinone 
reductase (SQR, complex II), ubiquinol-cytochrome-c reductase (QCR, complex ill), and 
cytochrome c-oxidase (CcO, complex IV) and the fifth complex is the ATP synthase 
(ATPase, complex V) (Scheme 1). NADH or succinate, which are derived from the citric 
acid cycle, are oxidized to NAO+ and fumarate by donating their electrons to ubiquinone 
through complex I or complex II, respectively. The electrons released are transferred to 
complex III then complex IV and finally to molecular oxygen. The energy released from 
the oxidation of NADH or succinate by the mitochondrial respiratory chain is conserved 
as an electrochemical proton gradient, which is then utilized by the ATP synthase 
complex to synthesize adenosine triphosphate (ATP) (1). 
The NADH-ubiquinone reductase complex or Complex I is the largest of these 
five complexes with a molecular weight of 907 kDa and is composed of 43 subunits. This 
complex catalyzes the electron transfer from NADH to ubiquinol. One FI\1N and seven 
different Fe-S clusters and at least three bound ubiquinone molecules constitute the redox 
prosthetic groups of this complex (2-6). 
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Scheme. 1. Electron transport complexes and ATP synthase in mitochondrial respiratory 
chain 
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The succinate-ubiquinone reductase or complex II, is composed of five subunits 
with a molecular weight of 127 K.Da. It catalyzes the electron transfer from succinate to 
ubiquinone, and contains five prosthetic groups: one FAD, three different Fe-S clusters 
and ab-type cytochrome (b560) (7-10). 
The ubiquinol cytochrome-c reductase complex or complex ill, also known as the 
bc1 complex, consists of eleven subunits and has a molecular weight 248 KDa. It 
catalyzes the antimycin-sensitive electron transfer from ubiquinol to cytochrome c (11). 
Detailed information about this complex will be presented in the next section. 
The cytochrome-c-oxidase (CcO) or complex IV is composed of 13 subunits and 
has a molecular weight 204 KDa. It catalyzes electron transfer from cytochrome-c to 
oxygen and has four redox prosthetic groups: two a-type cytochromes ( a and a3) and two 
copper centers CuA and CuB (12). 
Complex V also known as the ATP synthase is composed of two basic subunits 
Fl and Fo. Fo is a membrane sector and Fl is a water-soluble catalytic component that 
binds ADP and Pi and synthesizes ATP (13-15). 
The protonmotive Q-cycle Mechanism 
The bc1 complex acts as a "proton pump" that pumps protons across the membrane 
using the potential energy generated by the difference in redox potential between ubiquinol 
and cytochrome c. The most favorable mechanism for electron and proton transfer in the 
bc1 complex was first proposed by Peter Mitchell (16) as the "Q cycle mechanism" 
(Scheme 2) and modified later to explain electron transfer, proton translocation and the 2: I 
Jr/e· ratio in the cytochrome bcl complex. The two key features of the Q-cycle are: 
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1- The involvement of two separate binding sites for ubiquinone and ubiquinol: (i) 
Qp site where ubiquinol (QH2) is first oxidized near the P-side (positive side) of the inner 
mitochondrial membrane and (ii) ON site where ubiquinone (Q) is reduced near the N-side 
( negative side) of the inner membrane. 
2- The bifurcated reaction at the Qo site which involves the transfer of one 
electron to the high potential chain through the 2Fe2S cluster of the iron sulfur protein 
(ISP) to cytochrome c1 and then to cytochrome c, and the transfer of the second electron to 
the low potential chain through heme bL to heme bH, From heme bH, the electron is 
transferred to ubiquinone to form ubisemiquinone (Q·), which completes half of the Q-
cycle with one electron transferred to cytochrome c and two protons released on the P-side 
of the membrane. The second half of the cycle involves the oxidation of a second QH2 
molecule at the Qo site with one electron transferred to the high potential chain to reduce 
cytochrome c and the second electron transferred to the low potential chain to reduce 
ubisemiquinone to QH2 with the release of another two protons to the P-side of the 
membrane. In summary, a complete turnover of the cytochrome bc1 complex oxidizes two 
molecules of QH2 at the Qo site and generates one QH2 molecule at the Qi site with the 
reduction of two molecules of cytochrome c and the release of 4 protons on the P-side of 
the membrane: 
QH2 + 2 cytochrome c3+ + 2H\ +-+ Q + 2 cytochrome c2+ + 4Ir P 
P Center { 
2H+ 
a. Opt ISP-- c~c I b~ e· I 
I 1 bse2 I A a~ N Center { l J~ Q_., On·· 
Scheme. 2. Q Cycle mechanism shown in the frame of a functional monomer of the 
cytochrome bc1 complex. P center refers to the positive side of the membrane 
and N center refers to the negative side of the membrane. 
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A- Ubiguinol-cytochrome c reductase (The cytochrome bc1 complex or 
complexnn 
The ubiquinol-cytochrome c oxidoreductase is an oligomeric membrane protein 
complex and one of the fundamental components of the eukaryotic and bacterial 
respiratory chain (17, 18). The complex localizes in the inner mitochondrial membrane of 
eukaryotic organisms as well as in many aerobic and photosynthetic bacteria ( 1 7, 18). 
In mitochondria, the cytochrome bc1 complex (Fig. 1) catalyzes electron transfer from 
ubiquinol to cytochrome c, which is coupled to the translocation of protons across the 
mitochondrial inner membrane from the matrix space to the intermembrane space and 
contributes to the electrochemical proton gradient that drives ATP synthesis ( 18, 19). In 
addition to electron transfer and proton translocation, the cytochrome bc1 complex can 
also generate superoxide anion (10,20) and under some specific conditions it can exhibit 
mitochondrial processing peptidase activity (21 ). 
The bc1 complex was first purified from bovine heart mitochondria by Hatefi et al 
in 1962 (19). The purification procedure was modified later to yield this complex with 
higher purity and activity (20,22,23). The purified mitochondrial cytochrome bc1 
complex contains 11 protein subunits; it consists of 2165 amino acid residues and four 
prosthetic groups with a total molecular mass of 248 KDa (24-26). 
However, Saccharomyces cerevisiae (29) and Neurospora crassa complexes 
consist of only 10 subunits. 
42A 
75A 
Core1 
130 A 
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Fig. 1. Ribbon drawing of the dimeric bovine mitochondrial cytochrome bc1 complex . 
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1. The redox-containing subunits 
Only three of these subunits are catalytic subunits with essential redox prosthetic 
components and participate in electron transport; the two b-type hemes bL (bs6s) and bH 
( bs62) of cytochrome b, which is a mitochondrially encoded gene product, in addition to 
cytochrome c1 with a c-type heme and the iron-sulfur protein (ISP), also known as the 
Rieske protein, with one high potential iron-sulfur cluster [2Fe-2S] which are encoded by 
the nuclear genome (26). These three redox-containing subunits are essential subunits of 
the complex since they are present in all the cytochrome bc1 complexes and are directly 
involved in electron and proton transfer. 
2. Non-redox subunits (supernumerary subunits) 
The mitochondrial cytochrome bc1 complex contains additional subunits known as 
the non-redox active proteins or the supemumeral subunits. The number of supemumeral 
subunits in bc1 complex varies from one organism to another. There are eight 
supernumerary subunits in bovine bc1 complex (26), seven in yeast bc1 complex (27), one 
in the Rhodobacter sphaeroides (28) and none in Paracoccus denitrificans (29), 
Rhodospirillum rubrum (30) and Rhodobacter capsulatus (31 ). Their role in the complex 
has long been assumed to be structural rather than catalytic (26). 
3. Core I and Core II subunits 
Over one half of the complex mass, including subunits Core I and Core II (Fig. 2), 
are on the matrix side of the membrane, while most of the cytochrome b subunit is 
located within the membrane. There are 13 transmembrane helices in each monomer, 
(a) 
Corel Corell 
(b) 
Corell 
Fig. 2. (a) Ribbon drawing showing the a-helices of Core I (skyblue) and Core II 
(yellowtint). 
(b) Ribbon drawing showing a comparative model between the Core I/Core JI 
subunits of bc1 complex and the a-MPP/f3-MPP subunits of yeast MPP. 
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eight of them belonging to cytochrome b (26). The two large so-called core proteins Core 
I and Core II are extramembranous subunits that are attached to the transmembrane 
domains and protrude into the matrix. Both subunits are bowl-shaped and assembled to a 
hollow ball. Core I and Core II have 21 % sequence identity and their three-dimensional 
structures are remarkably similar (26). Each of these core subunits consists of two 
structural domains (the N-terminal and the C-terminal domains) of about equal sizes and 
almost identical folding topology (26). In the assembled bc1 complex, the NH2- terminal 
domain of Core I interacts with the COOR-terminal domain of Core II and the COOH-
terminal part of Core I interacts with the NH2-terminal domain of Core II (26). Both 
domains are folded into one mixed p sheet of six or five 13 strands surrounded by three a 
helices on one side and one a helix from the other domain on the other side (Fig. 3.) (26). 
Core I and Core II enclose a big cavity and the amino acid residues lining the walls of 
this cavity are mostly hydrophillic (32,33). The two subunits, Core I and Core II, are 
synthesized in the cytosol as large precursor proteins of 480 and 453 amino acid residues, 
respectively, with N-terminal extension peptides or presequences for targeting into the 
mitochondria (25). The 34 residues of Core I NH2-terminal and the 14 residues of core II 
NH2-terminal are proteolytically cleaved during or after the import of the precursors into 
the mitochondria (25). Removal of the presequences is necessary because they might 
interfere with the proper folding and assembly of the imported polypeptides or with the 
function of the protein. The core proteins of the mammalian bc1 complexes are 
homologous to the subunits of the general mitochondrial matrix processing peptidase 
(MPP) that functions in cleaving signal peptides of nuclear encoded proteins after import 
into the mitochondrion (34). 
(a) 
11 
--
Corel Core II 
(b) 
Residue 280 in Corell. 
Fig. 3. (a) Ribbon drawing showing the beta sheets of the Core I (skyblue), Corell 
(yellowtint) and subunit IX (red). 
(b) Ribbon drawing showing the Core I (skyblue), Core II (yellowtint), 
subunit IX (red), and the so-called glycine rich loop in the Core II subunit 
(green). 
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4. Additional Core I and Core II characteristics 
A cDNA encoding Core I subunit of bovine bcl complex was cloned and its 
ammo acid sequence was deduced from nucleotide sequencing (35,36). Besides its 
function in maintaining electron transport, the bovine Core I subunit, like Core I of 
Neurospora crassa bc1 complex, has processing peptidase activity. Comparison of the 
amino acid sequence of Core I with the sequence of the a-subunit of matrix processing 
peptidase (MPP) from Neurospora crassa revealed a high identity of 39% and a 
similarity of 49% (35). By studying several Core I mutants, it was established that the 
Core I subunit of the yeast bc1 complex is required for the assembly of the complex and 
the conversion of apocytochrome b to mature cytochrome b (37,38). Similarly, by 
studying core II-deficient mutants, it was found that the yeast core II is essential in 
maintaining proper conformation of apocytochrome b (39). Treatment of bovine bc1 
complex with N-(ethyl-carbonyl)-2-ethoxy-1,2-dihydroquinoline (EEDQ), a reagent that 
chemically modifies buried carboxyl groups resulted in the loss of proton pumping 
activity in liposome-reconstituted bc1 complex but with no effect on the passive proton 
pumping of the proteoliposomes (40). These results suggest that some carboxyl groups in 
Core II can be involved in proton pumping activity of the complex (40,41). 
Subunit VI interacts with cytochrome b of one monomer and with Core I and 
Core II of the other monomer. Core II and cytochrome b subunits contribute major dimer 
interactions across the two-fold symmetry of bovine bc1 complex. On the other hand, the 
presence of Core II on the negative side of the membrane, together with subunit VI., may 
contribute a possible proton pathway to the ubiquinone reduction site (32,33). However, 
based on the 3-D structure of the bovine be I complex, the distance between the Qi site 
13 
and core II is not close enough, hence, more evidences are needed to support this 
suggestion (26,41 ). 
5. Sequence alignment analysis 
The Core I protein of the bovine bcl complex presents 56% sequence identity with 
the ~ subunit of rat MPP, 3 8% sequence identity with the (3 subunit of yeast 1\.1PP and 
42% sequence identity with the p subunit of potato MPP, whereas Core II protein of the 
bovine bc1 complex is 27% identical to the a, subunit of rat MPP, 28% identical to the a. 
subunit of yeast MPP and 30% identical to the a. subunit of potato MPP (42,45). 
6. Subunit IX (presequence of ISP) 
As mentioned before, Core I and Core II subunits enclose a big cavity. This cavity 
is filled with subunit IX (Fig. 4.). The subunit IX of the bovine heart cytochrome bc1 
complex, with a molecular weight of 8.0 KDa, is the 78 amino acid presequence that is 
cleaved post-translationally from ISP (subunit V of the bc1 complex) as it is imported and 
targeted to the mitochondrial cytochrome bc1 complex. The Rieske protein in the bovine 
bc1 complex is processed in a single proteolytic step and is retained as a subunit (subunit 
IX) in the complex (27) and it should be noted that a homologous subunit is not present 
in Saccharomyces cerevisiae ( 46) and Neurospora crassa ( 4 7) because the processing of 
the ISP presequence is different and it is removed in two steps and degraded in vivo by 
another as yet unidentified protease. After undergoing a sequence alignment, 88% of the 
presequence was found to be identical between the bovine, human and rat species. 
Removing the presequence of ISP generated the mature ISP protein (27). 
42A 
ISP 
75A 
Core 1 
130 A 
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Fig. 4. Ribbon drawing of the dimeric bovine mitochondrial cytochrome bc1 complex 
showing the presequence of the iron-sulfur protein retained as a subunit (subunit 
IX) in the hollow cavity formed by the Core I and Core II subunits. 
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B- Mitochondrial Processing Peptidase {MPP): 
The majority of nuclear encoded mitochondrial proteins are synthesized with 
amino-terminal presequences that target the preprotein to the intra-mitochondrial location 
(matrix) where they are cleaved proteolytically by the mitochondrial processing peptidase 
(MPP) (47). 
The mitochondrial processing peptidases also known as the matrix processing 
peptidases are soluble heterodimeric proteins localized in the mitochondrial matrix and 
belong to a family of Zn2+ -dependent metalloendopeptidases whose members include 
insulin degrading enzymes from mammals and protease ID from bacteria. This family of 
metalloendoproteases is the pitrilysin family (47,48). 
Mammalian fvfPP consists of a and J3 subunits. The J3-MPP subunit contains the 
zinc-binding domain HXXEHX7~ and the active site of the protease, whereas the a-!\1PP 
subunit is thought to bind the leader peptide (44). 
The MPPs from Saccharomyces cerevisiae, rat liver and Neurospora crassa also 
contain the two a- and P- subunits. In Saccharomyces cerevisiae and rat liver both the a-
and J3-MPP subunits are located in the mitochondrial matrix (48-50), whereas in 
Neurospora crassa, the fl-subunit is located in the matrix ( 51) but the a-subunit is a 
membrane-associated protein (52). 
In plants, and more specifically in potato, spinach and wheat, the f\.fi>P subunits 
are the core subunits of the bc1 complex and are located in the mitochondrial inner 
membrane (44,53,54,55). 
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I. MPP from Saccharomyces cerevisiae 
The MPP from Saccharomyces cerevisiae contains two polypeptides with apparent 
molecular weights of 48 and 51 KDa and are believed to be only loosely associated 
together. Based on Comassie Blue staining, the purified enzyme shows an approximate 
1:1 ratio between the two polypeptides (48). The a-MPP was co-expressed with N-
terminal 6-His-tagged (3-MPP and both subunits assembled into a fully active and soluble 
enzyme after being co-eluted from a nickel-derivatized affinity resin with a 1 : 1 
stochiometry. Individually purified a- and (3-subunits are inactive (56,57) and 
functionally asymmetric. Cross-linking studies showed that purified a.-MPP is 
responsible for the binding of mitochondrial precursors before their presentation to the 
catalytic site of:MPP in the absence off3-MPP. 
2. MPP from rat liver 
Mammalian :MPP was successfully purified to homogeneity from rat liver 
mitochondria (49,50). The purified enzyme consists of two subunits; a-MPP (also called 
P-55) and f3-MPP (also called P-52) with apparent molecular masses of 55 and 52 KDa 
respectively. Unlike in Saccharomyces cerevisiae, these two subunits are very tightly 
associated forming a heterodimer complex (50). The c-DNAs encoding both MPP 
subunits from rat liver were over-expressed separately in E.coli and the recombinant 
proteins were successfully purified to homogeneity ( 58). Results showed that both 
subunits are required for the complex activity, which was reconstituted with a 
denaturation-renaturation protocol, and the binding of MPP to substrate peptides is found 
to be 30-fold greater in the dimeric complex than in each subunit monomer ( 59). 
17 
3. I\1PP from Neurospora crassa 
In Neurospora crassa the a-MPP and p-MPP are also called processing enhancing 
protein (PEP) ( 51 ). The purified enzyme consists of two polypeptides, a-MPP and f3-
MPP, with a 2.6: 1 molar ratio. The molecular masses of the two subunits are 57 KDa and 
52 K.Da respectively, estimated by SOS-PAGE. These two proteins do not form a 
complex when separated by FPLC gel filtration (52) but both subunits are required for 
IvfPP activity. The purified J3-MPP subunit from Neurospora crassa alone exhibited very 
low detectable processing activity. However, the addition of purified a-MPP, which also 
does not have any processing activity by itself, results in the stimulation of the processing 
activity, concluding that both of these subunits were required for the full processing 
activity. 
4. lVIPP from potato tuber 
Although the purification of MPPs from plants has not reached homogeneity level, 
it was reported that in potato and spinach leaf :MPP, the MPP activity co-fractionated 
with the mitochondrial membrane. In both latter species, MPP could not be dissociated 
from mitochondrial membrane even when treated with high pH (pH, 11 ), high 1oruc 
strength (IM KCL), chaotropic reagent (4M urea) or detergent (0.5% triton X-100). 
By comparing the processing activity of the membrane and the matrix portion 
toward a precursor protein, it was found that potato tuber mitochondrial membrane 
contains at least 100 times more processing activity than the soluble fraction. By 
immuno-precipitation with antibodies against Neurospora crassa MPP, the bc1 complex 
was identified as the protein complex associated with MPP activity (44). 
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5. MPP from spinach leaf 
The isolation of :MPP (bc1 complex) from spinach leaf mitochondria was 
accomplished by its solubilization from mitochondrial membrane with 50mM dodecyl f3-
maltoside followed by anion-exchange chromatography and gel-filtration 
chromatography. It was detected that :MPP activity was entirely associated with the bc1 
complex (55). 
6. Potato bc1 complex 
Potato bc1 complex consists of 10 protein subunits; three redox containing 
subunits which are cytochrome b, cytochrome c1 and ISP, and three core subunits with 
molecular masses of 55, 53 and 51 KDa, in addition to four other supernumerary subunits 
(44). The purified potato bc1 complex exhibits IvlPP activity. The three core subunits 
were identified by specific antibodies raised against Neurospora crassa Core I subunit 
( 60). However the separation of these three core subunits from the complex resulted into 
the aggregation of the remaining sub-complex and irreversible loss of processing activity 
(61). 
7. Spinach leaf bc1 complex 
Similar to potato bc1 complex, spinach bc1 complex consists of 10 protein subunits 
including three redox subunits, three core subunits with a molecular weight of 61 KDa, 
54 KDa and 52 KDa, and four supernumerary subunits. The relationship between spinach 
Core I protein and P-MPP and between Core II - Core ill proteins and a-MPP was 
19 
established after the recognition of Core I by specific antibodies raised against yeast (3-
MPP, and the recognition of Core II- Core III by antibodies against yeast a.-1\.{pP (55). 
C- Active sites of MPPs and bovine be! complex 
ivlPP belongs to the pitrilysin family of zinc metalloproteases because of the 
presence of a zinc-binding motif (Fig. 5). MPPs of different species share common amino 
acid motifs, including the zinc-binding motif. This zinc binding motifHXXEH(X)72-76E 
is located in the (3-MPP subunit of MPP and is actually the inversion of the thermolysin 
zinc binding motif HEXXHX ... (Fig. 6) ( 62). The histidine residues, together with the 
glutamic acid residue located 76 residues downstream, are involved in zinc binding and 
constitute the active site ofMPP (62-64). Most of the studies done on the active site(s) of 
l\1PP involve the HXXEHX76E motifs of MPPs. 
Moreover, it was recently discovered that distal and proximal basic amino acids 
from cleavage sites are required for an effective processing of the presequence (65,66). 
The distal basic sites are required as positively charged amino acids, lysine and arginine, 
and the proximal basic site should be an arginine residue located at the -2 position (P2). 
In addition, hydrophobic and hydrophillic residues at P 1 and P2-P3, respectively, are also 
important for effective catalysis (67-69). 
The a-:MPP regulates the catalytic activity of (3-ivlPP and participates in substrate 
recognition (70). A so-called glycine rich loop that belongs to the a.-MPP subunit was 
suggested to be involved in substrate binding and/or product release because of it's 
flexible loop structure (71). 
20 
I S74 _ ND1 
U1 37 _0E2 
Fig. 5. Drawing model representing residues of the yeast ~-MPP zinc binding site (red) 
superimposed with the residues of the Core I active site of the bovine bc 1 complex 
(blue). 
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Fig. 6. Drawing model representing residues of the thermolysin zinc binding site (white) 
superimposed with the residues of the Core I active site of the bovine bc1 complex 
(blue). 
22 
I. Active site of rat MPP 
In the rat (3-MPP, the histidine residues and glutamic acid residues of the 
HXXEHX76E motif were mutated individually, and these mutations decreased the 
processing activity, which explains the critical role of this motif in the processing activity 
of MPP (72-74). Some species contain another motif in the a-MPP subunit as the 
HXXEK motif in rat a-MPP, and mutations along this motif do not have the drastic 
effects as the ones resulted from mutations in the (3-MPP motif (74). More recently, 
individually mutating Glul91 and Asp195 of rat (3-MPP to alanine and quantifying their 
cleavage activities with that of the wild type using a synthetic substrate obtained 
evidences that these residues interact with the P2 arginine of precursor protein through 
ionic and hydrogen bonds, respectively. The EI91A and D195A MPP activities were 
about 50% and 6% of the wild type, respectively, whereas the combined mutation 
EI9IA/Dl95A showed more drastic effect on the activity compared to the wild type. 
Thus, both Glu 191 and Asp195 seem to be required for the cleavage of extension peptide 
(75). Hence, (3-MPP shows a predominant role in the formation of active site although 
no direct proof exists for rat (3-MPP to be the catalytic site (72-74). 
2. Active site of yeast MPP 
Unlike in yeast, mutations in the a- and (3-subunits indicate that the whole 
HXXEHX76E region is required for the proper formation of the active site of :MPP, and 
some structural contact was found between the motif and the a-MPP subunit (56). 
Substituting the first histidine residue to arginine terminated the zinc binding 
ability in the mutant (3-MPP (76). Besides, deleting a portion of the C-terminal fragment 
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in a-:MPP causes a significant decrease in binding ofJ3-MPP and in processing activity. In 
addition, the non-conserved central region surrounding lysine-124 of J3-MPP was found 
to be involved in the interaction with a-MPP (56). Recently, the crystal structures of 
recombinant yeast :MPP and a cleavage-deficient mutant of MPP-complexed synthetic 
presequence peptides was determined and it was found that MPP can bind the short 
peptide in the extended conformation within a large polar cavity (77). The substrate 
peptide interacts mainly with P-:MPP and its N-terminal site almost reaches the a-MPP. 
3. Active site of mitochondrial bc1 complex 
As for the mitochondrial bc1 complex, a similar zinc-binding motif is found in the 
Core I subunit. The main variations are that this motif Y57XXE60H6IX76EI37 has a 
tyrosine residue at the first position instead of histidine and the distal E 13 7 is close to the 
five-residue segment in the putative zinc-binding motif of Core I. Since, as mentioned 
before, histidine residues are required for :MPP active site, tyrosine was substituted to 
histidine. However, the reconstituted activity from Y57H Core I mutant with wild type 
Core II was the same as the reconstituted activity from wild type Core I and Core II, 
which suggests that both, tyrosine and histidine have identical roles in the active site of 
' 
MPP. Substitution of Y57 with phenylalanine or tryptophan also had no effect on the 
complex activity, however substitution with threonine eliminated the reconstitutive 
activity, revealing the functional importance of the aromatic group over the hydroxyl 
group in position 57 of Core I (78). 
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D- MPP activaty from bovine heart mitochondrial cytochrome be! complex 
Despite the sequence homology between Core I and Core II subunits of the 
bovine bc1 complex and the a- and P-subunits of MPP, no MPP activity was detected in 
the active bovine bc1 complex. 
The bovine heart mitochondrial cytochrome bc1 complex with electron transfer 
activity has no mitochondrial processing peptidase activity. The treatment of this 
complex with increasing concentrations of Triton X-100 at 37°C decreases the electron 
transfer activity and increases the peptidase activity. Complete inactivation of electron 
transfer with l.SmM Triton X-100, a maximum l\.1PP activity is observed. This l\1PP 
activity remains constant even with higher concentrations of Triton X-100. 
It was established that Triton X-1 oo disrupts the structural integrity of the bc1 
complex at certain concentrations, uncovered by the loss of its electron transfer activity. 
Hence, the extent of activity lost indicates the extent of bc1 structure disruption. 
It is suggested that the lack of fv.lPP activity in the mammalian cytochrome bc1 
complex is caused by the binding of an inhibitor polypeptide to the active site of 1\,fi>P 
located at the interface of Core I and Core n subunits. This suggestion is based on the 
three-dimensional structure of the bc1 complex and the sequence homology between 
subunits ofl\.1PP and the core subunits of beef bc1 complex. 
Hence, Triton X-100 weakens the binding of the inhibitor polypeptide to the 
active site of l\.1PP in core subunits and activates MPP action. (21) 
Similarly to Triton X-100, other non-ionic detergents such as Zwittergent, 
decanoyl-N-methylglucamide and octyl glucoside also activate MPP in beef cytochrome 
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bc1 complex. Even though ionic detergents, such as sodium cholate, deoxycholate and 
sodium dodecyl sulfate, and other chaotropic reagents such as urea and guanidine HCl 
inactivate electron transfer, :MPP activity is not detected after treating the crystalline bc1 
complex. This is believed to be due to their inhibitory effect on MPP rather than 
ineffective weakening of the binding of inhibitory polypeptide with the core subunits. 
The Triton X-100 activated MPP is pH buffer system, ionic strength, and 
temperature dependent (21 ). 
I . Optimal conditions for MPP activity 
:MPP is buffer system and ionic strength dependent. Higher activity is observed in 
Tris-HCl buffer than in phosphate buffer at pH 8.0. Maximal activity is detected in Tris-
HCl buffer at a concentration ranging between 15 and 50mM, and gradual activity 
decrease is observes at increasing Tris-HCl concentrations. In phosphate buffer, the 
maximal activity is 80% the maximal activity in Tris-HCl buffer, and similarly it 
decreases at concentrations higher than 15mM. For both buffer systems the Jv.lPP activity 
decreases with a salt concentration higher than 100 mM. 
The optimal pH for MPP activity is between 6.5 and 8.5. At pH values lower than 
6.5 a decrease in activity is observes but more drastic decrease is observed at pH values 
higher than 8.5 (21). 
Temperature wise, the maximal activity is observed at 37°C and drops drastically 
at 42°C because of some partial denaturation, unlike MPP in plant bc1 complex, which is 
active at 50°C (79). 
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The optimal conditions at which the maximal MPP activity is obseived is after 2 
hours of incubating the bc1 complex with 15mM Tris-HCl buffer pH 8.0 containing 
l.SmM Triton X-100 at 37°C. Prolonged incubation under the same conditions decreases 
slightly :MPP activity. 
:MPP activity requires the presence of metal ions but cannot be stimulated by the 
addition of divalent cations. The addition of metal ion chelators such as EDT A inhibits it 
and increasing concentrations of chelators gradually lowers it. But this chelator-inhibited 
activity is restored in different extents by the addition of divalent cations like F e2+, 
Zn2+, Co2+, Mn2+, and Mg2+ indicating how essential they are and required for l\1PP 
activity (21 ). 
l\.1PP is a substrate specific enzyme and this specificity is governed by the length 
of the NH2-terminal end of the mature subunit rather than the length of the COOH-
terminal end of the presequence. This conclusion was reached after synthesizing several 
polypeptides composed of various lengths of COOH-terminal presequences and NH2-
terminal sequences of mature subunits and tested as substrates to examine where 
specifically :rvtPP cleaves the peptide (21 ). 
E- Reconstitution of MPP activity from Core I and Core II subunits of 
bovine bc1 complex 
To study the structure-function of:MPP/bc1 complex, reconstituted active Core I 
and Core II subunits of bovine bc1 complex are required. 
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The reconstituted active subunits were obtained by gene expression where 
recombinant Core I and Core II were generated. The pET expression system was used for 
this purpose since it can introduce a 6-His-tag upstream of the N-terminus of the 
expressed protein, which allows a one-step purification of recombinant protein with Ni-
NT A gel. 
Hence, recombinant Core I and Core II were generated for reconstitution studies, 
and since p1SP is the natural substrate for :MPP/bc1 which cleavage product is subunit IX, 
pISP was generated for studies ofMPP/ bc1 inhibition by subunit IX (78) 
1. Expression conditions 
Several factors such as IPTG concentration, induction growth time, medium and 
temperature are believed to affect the expression of recombinant His-tagged Core L Core 
II, and pISP. 
The yield increases as the IPTG concentration and induction growth time are 
increased, reaching a maximum at O.SmM ofIPTG and 3 hours of post-induction growth. 
Running a western blot using antibodies against the respective proteins revealed that a 
post-induction growth longer than 3 hours results in a lower yield and increased 
degradative products. 
The expression levels for core L Core II and pl SP in E.coli are very high using LB 
medium at 37°C and represent almost 30% of the total cellular protein. However, 95% of 
the expressed protein was found in the inclusion precipitate and when they were 
solubilized in SM urea, dialyzed and passed through a Ni-NT A column, the proteins were 
recovered in very small amounts and inactive (78). 
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This problem was overcame by adding betaine and sorbitol to the LB medium to a 
final concentration of 2.5mM and 0.44M respectively, and with the IPTG induction done 
at 27°C for 3 hours (80,81 ). This solubilization increased the yield of the soluble 
expressed protein in E.coli, and about 6mg of purified recombinant Core I, 5mg of Core 
IT and 6mg of plSP were obtained from 500ml of their respective cell cultures. 
2. Reconstitution of:rvfi>P from purified recombinant Core I and Core II 
Like a.- and P- subunits of fvfi>P, individually purified recombinant Core I and 
Core II show no :rvfi>P activity. However, the activity is reconstituted by mixing the 
purified proteins together. The reconstituted l\,IPP activity increases as the molar ratio of 
Core I to Core II increases and maximum activity is detected when this molar ratio is 1. 
These results indicate that recombinant Core I and Core II are active. 
The MPP activity detected in Triton X-100 treated complex is associated with 
Core I and Core II and the structural integrity of the bc1 complex is not required for 
MPP/bcl activity. 
Similar to Triton X-100-activated l\,IPP in the bc1 complex, the processing activity 
of the reconstituted lv.lPP is inhibited by metal ion chelators. Likewise, the chelator-
inhibited activity can be partially restored by the addition of divalent cations and the most 
effective one is Zn2+, which leads to the conclusion that :rv1PP/bc1 is a Zn-
metallopeptidase. But the role of Zn2+ in l\1PP/bc1 and yeast J\.1PP is different, although, 
yeast l\.fPP has been also shown to be a zinc metallopeptidase (76). MPP/bc1 activity is 
not totally dependent on Zn2+ presence whereas in yeast, Zn2+ is required for l\.fPP 
activity. 
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The reconstituted :MPP/bcl substrate specificity, like Triton X-100 activated :rv.tPP 
in bovine bc1 complex, depends more on the length of the amino acid sequence of the 
mature protein portion rather than on the presequence portion (21 ). 
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Chapter II 
Interaction between Core I and Core II 
Subunits of Bovine bc1 Complex 
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In this chapter, a detailed scheme about plasmid construction, overexpression 
and purification of Core le-term His-ta/Core Iluntag complex and mutants generation will be 
discussed. To study the interaction between Core I and Core II, five mutations were 
designed in Core I subunit where the residues that are in close proximity to Core II were 
mutated to alanine. The expression level of Core I and the binding affinity of Core I to 
Core II in each of the mutants was analyzed and compared to wild type. 
A- Study of Core I/Core D interaction 
Core I and Core II proteins, which similarly to a-MPP and 13-MPP are not active 
unless found in a complex form, form a heterodimer complex in the bovine bc1 complex 
with two contact regions between them revealed in the crystal structure of the bovine 
complex (I). The first contact region is located between the C-terminal part of Core I and 
the N-tenninal part of Core Il and includes residues S291 and H289 of Core I (Fig. 7), 
and the second contact region is located between the N-terminal part of Core I and the C-
terminal part of Core II and includes residues E80 and K77 of Core I (Fig.8). These 
residues will be mutated singly and in combination to determine the essentiality of each 
in the binding affinity of Core I to Core II. 
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Fig. 7 . Drawing model representing the close distance between the residues H289, and 
S291 of the Core I subunits and one of Core II alpha helices. 
( 
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Fig. 8. Drawing model representing the close distance between the residues K77 
and E80 of the Core I subunits, and the so-called glycine rich loop of the 
Core II subunit. 
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Core I/Core II complex formation will be studied usmg site directed mutagenesis 
followed by Ni-NTA column separation, SOS-PAGE and Western Blot analysis. Mutant 
Core I will be expressed in a His-tagged vector whereas wild type core II will be 
expressed in an untagged vector. Hence, untagged core II will interact with tagged Core I 
and the complex can be purified by Ni-NTA column. Expressing the mutant Core I as a 
his-tag protein eliminated the possibility that that the mutation actually resulted in 
decreased expression level of the protein rather than decreased the binding affinity. For 
instance, if a mutation in Core I decreases the expression level of untagged Core I as 
compared to wild type, and wild type Core IT is expressed as a His-tagged protein, then 
less Core I will be available to interact with Core II and upon purification of the complex, 
mutant His-tagged Core I/ wild type untagged Core II ratio will be less than wild type 
His-tagged Core I/ wild type untagged Core II ratio even though the mutation does not 
actually affect the binding affinity of Core I to Core II. For this reason, expressing the 
mutant Core I as the His-tagged protein and wild type Core n as the untagged protein 
followed by purification by Ni-NTA column will remove all the excess wild type Core II 
and the only reason for a decreased mutant His-tag Core I/wild type untagged Core II 
ratio can be that the mutation in Core I affects the binding affinity of Core II to Core I. 
B- Materials 
LB broth and LB agar were purchased from Invitrogen and Life Technologies Inc. 
respectively. The TA Cloning kit was from Invitrogen. Taq DNA polymerase, T4 DNA 
ligase and restriction endonucleases were obtained from either Promega or Life 
Technologies,lnc. Kanamycin and ampicillin were from Fisher Scientific. Betaine, 
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sorbitol, pheny-methyl-sulfonyl fluoride, dimethyl sulfoxide, and imidazole were 
obtained from Sigma. Centriprep YM-30 was from Amicon. Nitrocellulose membranes 
were from Osmonics. Oligonucleotides were synthesized by the DNA/Protein Core 
Facility at Oklahoma State University or were obtained from Sigma Genosys. Antibodies 
against bovine bc1 complex were generated in rabbits and purified in our laboratory. 
Antibodies against His-Tag were obtained from Bio-rad. Isopropyl f3-D-
thiogalactopyranoside was from Bio Vectra. Plasmid "Mini-prep" kit, "Gel extraction" 
kit and Ni-NT A gel were purchased from Qiagen. Other chemicals were obtained 
commercially in the highest purity available. 
E.coli INVa'F (F'endA, recA, hsdRI 7 (rk-111tc-), supE44, thi-I, gyr96, re/AI, 
4>80/acZAmlS, A(/acZYA-argF)Ul69A-), E.coli BL21c+ (DE3) (F' ompT hsdS(rB- mB-) 
dcm+ Te{ gal A(DE3) endA Hte [argU ileY /euW Cam1 were used as hosts for pCR2.1 
(invitrogen) and for pET 22b+ or pET 30a+ (Novagen) plasmids. 
C- Experimental Procedures 
I . DNA Manipulation 
Mini-preparation of plasmid was performed according to Qiagen user's manual. 
DNA sequencing and oligonucleotide synthesis were performed by the Recombinant 
DNA/Protein Resource Core Facility at OSU. 
2. Isolation of cDNAs of Core I and Core II 
The cDNAs for Core I and Core II were isolated from bovine heart cDNA library 
m AZAP (Stratagene) by PCR amplification. Sense- and antisense- primers were 
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synthesized based on the 5'-end and 3'-end of the cDNA sequences of mature Core I and 
Core II with restriction enzyme sites at the 5'-end of the oligonucleotides (2). 
3. Construction of Core I and Core II expression vectors 
The Ndel-HindIIJ. Core I fragment and the Ndel-HindITI. Core II fragment were 
ligated to an enzyme-cut pET 22b + and pET 30a + vector, respectively. Both vectors 
contain a gene encoding a 6His-tag located upstream of the multiple cloning site to allow 
one step purification of Core I or Core Il with Ni-NT A affinity column. The resulting 
plasmids, pET22b + /Core I and pET30a + /Core II were transformed into BL2 l c \DE3) 
competent cells by chemical transformation. The core proteins expressed by the E. coli 
transfonnants were identified by western blot using antibodies against bovine bc1 
complex. 
4. Generation of pET /Core I C-tenninat His-tag and pET /Core II e-tenninal His-tag 
The DNA fragments encoding mature Core I and Core II were amplified by 
polymerase chain reaction (PCR) using in each case two specific synthetic primers 
containing the full restriction site of the specified endonucleases (Ndel or Hindill) at 
their 5' ends, using the pET/Core IN.terminal His-tag and pET/Core IIN-terminal His-tag (2) as 
template, respectively. 
The following primers were used for Core I amplification: 
Ndel 
sense primer 5' -CATATGATACCGCCACCGCCACCTACGCC- 3' 
antisense primer 5'-AAGCTIGAAGCGCAGCCA- 3' 
Hindlll 
The following primers were used for Core II amplification: 
sense primer 
antisense primer 
Ndel 
5' -CATATGGTCCCTCAAAGTTGCT- 3' 
5' -AAGCTTCAACTCATCAATGAA- 3' 
Hindlll 
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The PCR mixture contained Ix Mg free PCR buffer, 75pmoles MgCh, 125ng of 
each of the sense primer and anti-sense primer, 50ng of the respective template, 
20nmoles dNTPs and 2.5 units of Taq polymerase. 
The PCR reaction was performed as follows: initial denaturation at 94 °C for I 
minute, denaturation at 94°C for 45 seconds, hybridizing at 55°C for 30 seconds and 
extension at 72°C for 1.5 minutes. The reaction was carried through 16 cycles with a final 
extension step at 75°C for 10 minutes. Four µI of PCR mixture was electrophoresed on a 
I% agarose gel, stained with ethidium bromide, to confirm the size of the PCR product. 
The generated Ndel-Hindlll fragments encoding Core I or Core Il were digested with 
the proper enzymes (Ndel and Hindill) and ligated to their respective vectors 
(Scheme. 3): 
Core I fragment was ligated to Ndel-Hindill digested pET22b+ to generate the 
plasmid pET/Core le.terminal His-tag 
Core II fragment was ligated to Ndel-HindID digested pET30a+ to generate the 
plasmid pET/Core Ile-terminal His-tag 
Ligated plasmids were transformed to BL2 l c + (DE3 ). pET /Core le-terminal His-
taglBl2 l c + (DE3) cells were selected on ampicillin plates and pET/Core Ile-terminal His-
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iag/BL2 l c +(DE3) cells were selected on kanamycin plates. The sequences of the inserts 
were confirmed by DNA sequencing. 
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1e following primers 
:re used for Core I 
sense primer /4. antisense primer 5' -CAT ATG AT ACCGCCACCGCCACCT ACGCC 5'- AAGCTIGAAGCGCAGCCA- 3' 
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Ndel 
5' -CATATGGTCCCTCAAAGTIGCT- 3' 
5' -AAGCTICAACTCATCAATGAA- 3' 
Hind Ill i PCR 
Core II Core I 
-CATATG-- -----~MGCTI-A -CATATG AAGCTI-A 
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Hind Ill 
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TTCGA 
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Nde l 
Scheme. 3. Generation of Core l c -tenn His-taglpET22b + and Core Ilc -1em1 His-tagfpET30a + 
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5. Generation of Core Ilmrtag{pET30a + 
The (His )6 tag was deleted from the pET /Core Ilc-temuna1 ms-tag plasmid by the 
QuickChange® site directed mutagenesis method using the QuickChange® site directed 
mutagenesis kit from Stratagene in addition to two specific synthetic primers from 
Sigma, to generate the pET/Core Iluntag• 
The following primers were used: 
sense primer 
anti-sense primer 
5' -CGGCCGCACTCGAGTGAGATCCGGCTG- 3' 
3' -GCCGGCGTGAGCTCACTCTAGGCCGAC- 5' 
The QuickChange® site directed mutagenesis reaction contained lx cloned pfu 
buffer, 50ng of the template pET/Core Ile.terminal His-tag, 125ng of each of the sense and 
antisense primers, 25nmolesdNTP, and 2. 5 units of p.fu polymerase. The QuickChange ® 
site directed mutagenesis reaction was performed as follows: initial denaturation at 95 °C 
for 30 seconds, denaturation at 95°C for 30 seconds, hybridization at 55°C for I minute 
and extension at 68°C for 12 minutes. The reaction was carried through 18 cycles. The 
product of this reaction was first digested with Dpnl to digest the parental strands and 
then transformed to XL I-Blue. The plasmid was purified from XL I-Blue and sequenced 
to confirm the mutation and then transformed to BL2lc+(DE3). pET/Core 
Ilun1ag/BL2Ic+(DE3) cells were selected on kanamycin plates. 
6. Co-transformation ofpET/Core le-tenninaIHis-tagX pET/Core II~ 
Competent cells were prepared from pET/Core 1Iumag/BL21c+(DE3). 
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pET/Core le-terminal His-tag was then transformed into pET/Core IluntaglBL2lc+(DE3), and 
cells were selected on ( ampicillin+kanamycin) plates to generate: 
[pET/Core le-terminal His-tag x pET/Core IluntaJIBL2lc+(DE3) 
7. Generation of pET / Core le-terminal His-tag mutants 
pET/Core le-terminal His-tag were generated by QuickChange® site directed 
mutagenesis reaction, following the reaction mentioned above except that the template 
used is pET I Core le-terminal His-tag and the following primers were used for each mutant: 
E80A mutant: 
sense primer 
5' -GCCTTGGAGAAGGAGGTGGCGAGCATGGGGGCCCATC- 3' 
anti-sense primer 
3' -CGGAACCTCTTCCTCCACCGCTCGTACCCCCGGGTAG- 5' 
S291A mutant 
sense primer 
5' -GGTGGCGGAGCGCACCTGGCCAGCCCACTGGCTTCCA TTG- 3' 
anti-sense primer 
3' -CCACCGCCTCGCGTGGACCGGTCGGGTGACCGAAGGT AAC- 5' 
K11A 
sense primer 
5' -CCTGGCAA TGCCITGGAGGCGGAGGTGGAGAGCATGGGGG- 3' 
anti-sense primer 
5' -CCCCCATGCTCTCCACCTCCGCCTCCAAGGCA TTGCCAGG- 3' 
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H289A 
sense primer 
5' -CGGTGGCGGAGCGGCCCTGTCCAGCCCAC- 3' 
anti-sense primer 
5' -GTGGGCTGGACAGGGCCGCTCCGCCACCG- 3' 
The QuickChange® site directed mutagenesis reaction was performed as 
mentioned above. The product of this reaction was first digested with Dpnl to digest the 
parental strands and then transformed to XL I-Blue. The purified plasmid' s sequence was 
confirmed by DNA sequencing and transformed to BL21c+(DE3). pET/Core le-terminal His-
taglBL21 c + (DE3) mutant cells were selected on ampicillin plates. 
8. Generation of the double mutant pET /(E80A/S29 l A)-Corele-terminal His-tag 
The generation of the double mutant pET /(E80A/S29 l A)-Core le-terminal His-tag was 
performed by QuickChange® site directed mutagenesis reaction as mentioned above 
except that pET/S29IA-Core Ic-tenninal His-tag was used as template and the ESOA mutant 
sense and anti-sense primers listed above were used. 
9. Co-transformation 
pET /Core Ic-tenninal His-tag mutants were transformed to already prepared pET /Core 
II untag/BL2lc+(DE3) competent cells, and cells were selected on (ampicillin+kanamycin) 
plates to generate the following [pET/Corelc-tenninat His-tagX pET/Corelluntag]/BL2lc+(DE3) 
mutants: 
- [pET / K 77 A-Core lc-tenrunat His-tag x pET /Core Iluntag]/BL2 l c + (DE3) or K 77 A 
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- [pET/ E80A-Core 1c.tennmat His-tagX pET/Core Iluntag]/BL21c+(DE3) or E80A 
- [pET / H289A-Core le-terminal His-tag x pET/Core Iluntag]/BL21 c +(DE3) or H289A 
- [pET/ S291A-Core lc.tennmatHis-tagX pET/Core Iluntag]/BL2lc+(DE3) or S291A 
- [pET/(E80NS291A)-Core le-terminal His-tag x pET/Core IluntaJBL21c+(DE3) or 
E80NS291A 
10. Co-Expression of recombinant Core Ictemuna1 His-tag /Core Il !!!!l!!Lcomplex in 
E.coli 
A fresh colony is inoculated in 25ml LB broth in a 125ml flask containing 
125µg/ml ampicillin and 50µg/ml kanamycin and grown overnight at 37°C. The whole 
inoculate is then transferred to a 2 liters flask containing 500ml LB broth containing 
2.5mM betaine and 0.44M sorbitol, in addition to ampicillin and kanamycin to the 
corresponding final concentration. Cells were grown at 37°C until 0.0600 reached 0.7. 
The medium is then cooled down to the required induction temperature (23°C) and 
induced for 3 hours with l.OmM IPTG (lOOmM IPTG stock solution was used). Cells are 
harvested by centrifuging the whole medium at 8000xg for 25 minutes. About 2. 0 g of 
cell paste per 500ml culture were obtained and stored at -20°C until used. 
11. Core I/Core Il complex Purification 
Around 2.0 gram of cell paste, obtained from 500ml of cell culture, were 
suspended in 8.0ml of 50mM sodium/phosphate (Na/K) buffer, pH 8.0, containing 
JOOm.M NaCl (PBS). Phenylmethylsulfonyl fluoride (PMSF) was added to a final 
concentration of 1.0mM from a stock solution of SOOmM in dimethyl sulfoxide (DMSO). 
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Some DNase, RNase and magnesium chloride MgCh were added to the suspended cells 
in very small amounts. The cells were broken by sonication using Fisher ultrasonics cell 
disruptor two times for 1.5 minutes with a 2 minute-interval. Triton X-100 was added to 
the broken cell suspension to a final concentration of 1% (w/v). The suspension was then 
stirred for 45mins at 0°C and centrifuged at 19K for 25 minutes. 
The supernatant was recovered and applied twice in a very slow flow rate to 10ml 
of Ni-NT A agarose slurry gel, which was equilibrated with the sonication buffer (PBS). 
The column was first washed with the sonication buffer until the UV absorption at 280 
nm of the effluent dropped reached below 0.01. The column was then washed with 20-
column volume of 50mM Na/K phosphate buffer pH 6.0, containing 300mM NaCl and 
I 0% glycerol, followed by another 20-column volume wash with sonication buffer 
containing 20 mM imidazol. The last washing step was done with 15-column volume of 
sonication buffer containing 35mM imidazol. The recombinant core proteins were then 
co-eluted from the column with 15ml of sonication buffer containing 1 OOmM imidazol 
and O.01 %LM. The eluted solution was concentrated to a final volume of 600µ1 by 
centriprep YM-30 and frozen at-80°C until use. 
12. SDS-P AGE and Western Blot 
Proteins were treated with 1% P-mercaptoethanol and 1% SOS for 2 hours at 
37°C. Different amount of the digested samples were applied to the wells of a 10% SOS-
PAGE gel. 
Analytical 10% SOS-PAGE was performed in a Bio-Rad Mini-Protein dual slab 
cells. 
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The proteins on the SDS-P AGE gels were electrophoretically transferred to a 
nitrocellulose membrane. The membrane was blocked with 20mM Tris-Cl buffer pH 7 .5, 
500mM NaCl (TBS), containing 3% gelatin for one hour at room temperature and 
washed with TBS for 5 minutes and with TBS containing 0.05% Tween-20 (TTBS) for 5 
minutes. The membrane was then incubated with anti-mitochondrial bc1 antibodies 
(15µg/ml) in TTBS containing 1% gelatine at room temperature overnight. After 
incubating with the primary antibodies, the blots were washed twice with TTBS for S 
minutes and then incubated with the protein A-HRP conjugate (1:2500 in TTBS 
containing I% gelatin) for one hour. After washing the membrane with TTBS and TBS 
for 5 minutes respectively, the proteins were detected by showing HRP color 
development with hydrogen peroxide as substrate. Prestained protein molecular weight 
standard was used to estimate the size of proteins on the gel and the membrane. 
The prestained protein molecular weight standard contained phosphorylase B 
113.000Da, bovine serum albumin 92,000Da, ovalbumin 52.300Da, carbonic anhydrase 
35.3000a, Soybean Trypsin inhibitor 28.700Da, Lysozyme 21.3000a. 
13. Densitometric analysis 
The densitometric study was done with a GS-700 imaging densitometer using a 
captured picture of the SOS-PAGE. 
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D- Results and Discussion 
The Core I/Core II complex interaction can be studied in two ways: in vivo or in 
vitro. In in vitro studies, each of Core I and Core II is expressed separately in E-co/i 
followed by the protein purification. Afterward, Core I and Core II are mixed together 
and the complex is purified. In this case, if Ni-NT A column is to be used for the complex 
purification, only one of the two proteins can be tagged with histidine and purified by Ni-
NT A. If both proteins are tagged, the complex can be purified by gel filtration. In in vivo 
studies, both proteins are co-expressed in the same cell with one of the two proteins 
tagged followed by purification of the complex by Ni-NTA column. The latter method 
was used in this study to analyze the effect of several mutations on the interaction of Core 
I with Core II. For this purpose, an expression vector for each of Core I and Core II 
proteins was constructed and both were expressed in the same E-coli cell. As explained in 
the previous chapter, the his-tag should be on the mutated subunit to eliminate the error 
of the effect on the expression of the protein. In this study, the residues mutated for the 
interaction study are located on Core I, hence, Core I protein is his-tagged whereas Core 
II is not and the complex is purified by Ni-NT A column. The conditions used to co-
express and purify the recombinant Core IHis-1ag/Core Il complex from a single cell are 
stated in the Materials and Methods section. 
Theoretically, Core I and Core Il amounts in crude cell extract should be similar 
on SDS-P AGE stained with Coomassie Blue. However, Core I protein seems to be 
predominant, which is due to a much better expression of Core I compared to Core II. 
Densitometric analysis of Core I to Core II ratio in crude cell extract is around 4.0, which 
means that Core I is expressed 4 times better than Core II. 
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In the soluble fraction of the cell extract, Core I and Core Il amounts are almost 
the same with Core I slightly more than Core II. 
Around 10% of Core I proteins of the crude cell extract were expressed as soluble 
proteins and 90% were expressed in the inclusion bodies. Whereas 35% of Core II 
proteins of crude cell extract were expressed as soluble protein and 65% as inclusion 
bodies. As mentioned before Core I protein is four times more expressed than core II in 
the crude cell extract, which explains the slight abundance of the soluble fraction of Core 
I compared to Core Il. 
Structural integrity of these two proteins is studied by mutating several residues in 
Core I in the two contact regions where the distance between Core I and Core II is 
minimal. After constructing the Core I mutants co-expressed with Core Il in E. coli and 
purifying the complex with Ni-NTA affinity column, a comparative study was done to 
examine the effect of these mutations first on the protein expression and second on their 
structural integrity. The comparison was done in the eluted sampled between each of the 
mutant complexes and the wild type complex. The wild type complex is Core I c.tenn His-
1a/Core II untag. The mutated residues in Core I are K77, E80 and S29 l. Each of these 
residues was mutated to alanine individually to generate the Core I mutants K77 A-Core 
le-term His-tag, E80A-Core le.term His-tag and S29IA-Core le-term His-tag, respectively. In 
addition, a double mutant was constructed, (E80A/S29 l A)Core le-term His-tag, where both 
residues E80 and S29 l were mutated to alanine. 
As compared to wild type, only around 50% of Core I is expressed in E80A-
Corele-tenn His-ta/Core Iluntag whereas the expression level of Core I in each of the mutants, 
K77 A-Corele-term His-tawCore Iluntag and S291A-Corel c-term His-ta/Core Ilun1ag is around 90% 
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of wild type (Fig. 9). These results suggest that mutating the residue ESO to alanine 
significantly decrease the expression level of Core I while mutating either of residues 
K77 and S29 l to alanine has a minimal effect on the expression. In the double mutant 
(E80A/S291A)-Core le-term His-ta/Core IIuntag, the level of Core I expression is equal to the 
level of Core I expression in ESOA-Core le-term His-ta/Core IIun1ag, which is 50% of wild 
type Core I (Fig. 9). The decrease in Core I expression level can be explained by the 
degradation of the expressed protein by the cell as being a toxic foreign protein. 
To study the structural integrity between Core I and Core II, the ratio of Core I to 
Core Il was calculated with Core I set as control (I 00%) and the amount of Core II was 
compared to its respective Core I. The calculation was done based on the densitometric 
integration. The ratio of Core I to Core Il reflects the structural binding affinity of Core I 
to Core II. The closer the ratio is to 1.0, the higher the affinity binding is between the 
subunits. In the wild type complex, Core II amount is 90% that of Core I amount in the 
eluted sample (Core I to Core II ratio is I. 1) (fig. 10.). The amount of Core I is slightly 
higher than Core II since the His-tag is located on Core I. In bot~ K77 A-Core le-term His-
tag!Core Iluntag and S29 l A-Core le-term His-ta/Core Il untag, the amount of Core Il is 90% 
the amount of Core I (Core I to Core Il ratio is I. I) and hence comparable to wild type, 
which implies that individually mutating each of the residues K77 and S291 to alanine do 
not affect the binding of Core I to Core Il. However, the amount of Core Il is 80% the 
amount of Core I (Core I to Core Il ratio is around 1.25) in the eluted sample of the 
double mutant (E80A/S291A)-Core le-term His-tag/Core Iluntag (Fig. 10). This effect implies 
that mutating residue ESO to alanine affects the binding of Core I to Core II. Based on 
these results, it is likely that the charged residue glutamic acid at position 80 in Core I is 
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favored for better affinity binding between Core I and Core II whereas at position 77 or 
291, either lysine (K) or serine (S), respectively, or alanine (A) allow preeminent 
interaction in the complex. 
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Fig. 9. SOS-PAGE of recombinant complex Core I e-tennHis-Tar/ Core II untag· Insoluble cell 
extract were suspended in suspension buffer in the same volume as that of total cell 
extract. The volume of soluble extract was adjusted to the same as that of total cell 
extract. Four µl were used on SDS-P AGE for total cell extract, soluble and 
insoluble cell extract. Lane 1: molecular standard (ovalbumin 49.3 kDa); lane 2: 
total lysate of the wild type Core I e-tenn His-ta/ Core II un1ag; lane 3: soluble fraction 
of the wild type Core I e-tenn His-ta/ Core II umag; lane 4: insoluble :fraction of the wild 
type Core I c-term His-tag/ Core II umag; lane 5: total lysate of the mutant Core I S291A 
c-tenn His-tag I Core II untag; lane 6: soluble fraction of the mutant Core I S291Ac-term 
His-Tag/ Core II untag; lane 7: insoluble fraction of the mutant Core I S291Ac-term His-Tar/ 
Core II untag; lane 8: total lysate of the mutant Core I E80Ac-term His-Tad Core II umag; 
lane 9: soluble fraction of the mutant Core I EBO.Ac.term His-Tad Core II un1ag; lane 1 O: 
insoluble fraction of the mutant Core I E80Ae-tenn His-Ta/ Core II un1ag; lane 11: 
molecular standard (ovalbumin 49.3 kDa); lane 12: total lysate of the mutant Core I 
K77 Ac{His')6-Tag/ Core II untag; lane 13: soluble fraction of the mutant Core I K77 Ac-
(His)6-Ta8' Core II umag; lane 14: insoluble fraction of the mutant Core I K77 Ac-term His-
Tag/ Core II umag; lane 15: total lysate of the double mutant Core I [E80A/S291A] e-
tenn His-Ta8' Core II untag ; lane 16: soluble fraction of the double mutant Core I 
[E80A/S291A]c.1enn His-Tad Core Il umag; lane 17: insoluble fraction of the double 
mutant Core I [E80A/S291A]c.term His-Tag/ Core II un1ag; lane 18: total lysate of the 
mutant Core I H289A C-term HisTag/ Core II untag ; lane 19: soluble fraction of the 
mutant Core I H289Ac-tenn His-Ta/ Core II umag; lane 20: insoluble :fraction of the 
mutant Core I H289 Ac-term His-Tag/ Core II untag. 
56 
1 2 3 4 5 6 7 8 9 
A 
I t 
1 2 3 4 5 6 7 8 9 
B 
1 2 3 4 5 6 7 8 9 
C 
Fig. 10. (A) SDS-PAGE of recombinant complex Core I C-terrn His-Tag/ Core II untag· (B) 
Western-blot of the samples in (A) using mitochondrial bc1 complex antibody as 
first antibody. (C) Western-blot of the samples in (A) using His-tag antibody as 
first antibody. Lane 1: molecular standard (ovalbumin 49.3 kDa); lane 2 : total 
lysate of the wild type Core I c-tenn His-tag; lane 3: total lysate of the wild type Core 
II untag; lane 4: eluted sample of the wild type Core I c-tenn His-tag/ Core II untag; lane 
5 :eluted sample of the mutant Core I E80A c-term His-Tag/ Core II untag; lane 6: eluted 
sample of the mutant Core I S29 l Ac-term His-Tag/ Core II untag; lane 7: eluted sample 
of the double mutant Core I [E80NS291A]c_1erm His-Tag/ Core II untag; lane 8: eluted 
sample of the mutant Core I K77 A c-term His-Tag/ Core II untag; lane 9: eluted sample 
of the mutant Core I H289 A c-term His-Tag/ Core II untag . 
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Strain Core I Expression 
W.T 100% 
K77A 90% 
E80A 50% 
S291A 90% 
H289A 90% 
E80A/S291A 50% 
Table. 1. Comparative table for Core I expression in Wild type and mutant Core I. 
Wild Type Core I expressed in the crude extract was set as control (100%). 
Each of the expressed mutants Core I in the respective crude extract was 
compared to wild type. 
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Strain Binding affinity of Core II to Core I 
W .T 90% 
K77A 90% 
E80A 80% 
S291A 90% 
H289A 90% 
E80A/S291A 80% 
Table 2: Comparative table for the binding affinity between Core I and Core II. In the 
eluted sample of wild type and each of the mutants, Core I and Core II were 
quantified and compared to each other by setting Core I as control (100%) and 
comparing Core II to it. 
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E- Conclusion 
As compared to wild type, K77A, H289A and S291A mutants do not seem to 
have any significant effect on the expression level of Core I and the binding affinity of 
Core II to Core I. Therefore, mutating the polar residue at position 77, 289 or 291 to a 
nonpolar residue do not affect the interaction between Core I and Core II, which suggest 
that these residues are not involved in any electrostatic interaction with other residues in 
Core IT. On the other hand, E80A mutation in Core I affects the expression level of Core 
I and the binding affinity of Core Il to Core I. Hence, mutating the charged residue 
glutamic acid at position 80 to a nonpolar residue may be disrupting the structural 
integrity between Core I and Core Il to a certain extent. The side chain of glutamic acid at 
position 80 is pointed towards the so-called glycine rich loop in Core II and is 3.6A 
distant from Aspargine 290 in the loop (Fig. 11 ), which may predict hydrogen-bonding 
between the two residues. Therefore, changing the polarity of the residue at position 80 of 
Core I may disrupt the hydrogen-bonding interaction and affect the affinity binding 
between Core I and Core II. 
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Fig. 11. Drawing model representing the close distance between residues E80 of Core I 
subunit and residue N290 of the so-called glycine rich loop of Core II subunit. 
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